Okagaki T, Ye L H, Samizo K, Tanaka T, Kohama K
Department of Pharmacology, Gunma University School of Medicine, Maebashi, Gunma, 371-8511, Japan.
J Biochem. 1999 Jun;125(6):1055-60. doi: 10.1093/oxfordjournals.jbchem.a022386.
The catalytic domain of myosin light chain kinase (MLCK) not only exerts kinase activity to phosphorylate the 20 kDa light chain but also inhibits the actin-myosin interaction. The site of action of this novel role of the domain has been suggested to be myosin [Okagaki et al. (1999) J. Biochem. 125, 619-626]. In this study, we have analyzed the amino acid sequences of MLCK and myosin that are involved in the inhibition. The ATP-binding peptide of Gly526-Lys548 of chicken gizzard MLCK exerted the inhibitory effect on the movement of actin filaments on a myosin-coated glass surface. However, the peptide that neighbors the sequence failed to inhibit the movement. The inhibition of the ATP-binding peptide was confirmed by measuring ATPase activities of the myosin. The inhibition by parent MLCK of the movement was relieved by the 20 kDa light chain, but not by the 17 kDa myosin light chain. The peptide of the 20 kDa light chain sequence of Ser1-Glu29 also relieved the inhibition. Thus, the interaction of the ATP-binding sequence with the 20 kDa light chain sequence should cause the inhibition of the actin-myosin interaction. Concerning the regulation of the inhibition, calmodulin relieved the inhibitory effect of MLCK on the movement of actin filaments. The calmodulin-binding peptide (Ala796 Ser815) prevented the relief, suggesting the involvement of this sequence. Thus, the mode of regulation by Ca2+ and calmodulin of the novel role of the catalytic domain is similar, but not identical, to the mode of regulation of the kinase activity of the domain.
肌球蛋白轻链激酶(MLCK)的催化结构域不仅具有激酶活性,可使20 kDa轻链磷酸化,还能抑制肌动蛋白-肌球蛋白的相互作用。该结构域这一新功能的作用位点被认为是肌球蛋白[冈垣等人(1999年)《生物化学杂志》125卷,619 - 626页]。在本研究中,我们分析了参与抑制作用的MLCK和肌球蛋白的氨基酸序列。鸡砂囊MLCK的Gly526 - Lys548的ATP结合肽对肌球蛋白包被的玻璃表面上肌动蛋白丝的移动产生抑制作用。然而,与该序列相邻的肽未能抑制移动。通过测量肌球蛋白的ATP酶活性证实了ATP结合肽的抑制作用。亲本MLCK对移动的抑制作用可被20 kDa轻链解除,但不能被17 kDa肌球蛋白轻链解除。Ser1 - Glu29的20 kDa轻链序列的肽也能解除抑制作用。因此,ATP结合序列与20 kDa轻链序列的相互作用应会导致肌动蛋白-肌球蛋白相互作用的抑制。关于抑制作用的调节,钙调蛋白可解除MLCK对肌动蛋白丝移动的抑制作用。钙调蛋白结合肽(Ala796 Ser815)可阻止这种解除作用,表明该序列参与其中。因此,Ca2 +和钙调蛋白对催化结构域新功能的调节模式与该结构域激酶活性的调节模式相似,但并不相同。